The CRISPR Technology market is driven by rapid advancements in genome editing techniques, increasing investments in biotechnology and healthcare, a rising incidence of genetic disorders, increasing applications in agriculture, and the potential for personalized medicine. The detailed and constructive formation of key drivers, opportunities, and unique segmentation outputs structural and optimistic data.